TAVR for aortic valve regurgitation: Ready for a randomized trial?

Jorge Belardi; Pablo Lamelas

doi:10.1002/ccd.28079

TAVR for aortic valve regurgitation: Ready for a randomized trial?

Catheter Cardiovasc Interv. 2019 Feb 1;93(2):354-355. doi: 10.1002/ccd.28079.

Authors

Jorge Belardi¹, Pablo Lamelas^{1

2}

Affiliations

¹ Department of Interventional Cardiology and Endovascular Therapeutics, Instituto Cardiovascular de Buenos Aires, Buenos Aires, Argentina.
² Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.

PMID: 30719856
DOI: 10.1002/ccd.28079

Abstract

Transcatheter aortic valve replacement has been used successfully to treat native aortic valve regurgitation. Current observational evidence shows promising results in terms of procedural success while outcome data are difficult to interpret given the observational nature of the evidence. We are ready for a randomized trial, which will be very challenging to run.

Publication types

Editorial
Comment

MeSH terms

Aortic Valve / surgery
Aortic Valve Insufficiency / surgery*
Aortic Valve Stenosis / surgery*
Heart Valve Prosthesis Implantation*
Heart Valve Prosthesis*
Humans
Transcatheter Aortic Valve Replacement*
Treatment Outcome